Spotlight: High-Content Discovery and the Future of Phenotypic Screening with Claudia McCown, PhD (UF Scripps)

April 2
21 mins

Episode Description

In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Claudia McCown, a leader in high-content screening and phenotypic discovery, to explore how imaging, automation, and AI are transforming modern drug discovery. Drawing on her work at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Dr. McCown shares how the field is evolving from traditional high-throughput screening to data-rich, image-based approaches that reveal deeper biological insight.

What You’ll Hear:

  • From Throughput to Insight – Dr. McCown’s journey from classical screening approaches to high-content, image-based discovery.
  • Phenotypes at Scale – how high-content screening captures complex cellular behaviors that traditional assays miss.
  • AI Meets Imaging – the role of automation and machine learning in accelerating and refining biological analysis.
  • Collaboration Across Disciplines – lessons from bridging academia, biotech, and technology platforms like Araceli’s Endeavor.
  • The Future of Discovery – how integrated workflows will reshape drug discovery and empower the next generation of scientists.


🌐 Explore & Connect
Learn more about Dr. Claudia McCown’s work in high-content screening at UF Scripps and how collaborations with Araceli Biosciences are advancing phenotypic discovery.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us on the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague interested in the future of imaging, AI, and drug discovery.

🔗 Links

See all episodes